{
  "metadata": {
    "title": "Editorial Comment: Validation Study for the N Descriptor of the Newly Proposed 9th Edition of the TNM Staging System Proposed by the International Association for the Study of Lung Cancer",
    "year": 2024,
    "authors": [
      {
        "given": "Merve A.",
        "family": "Türk",
        "suffix": null,
        "degrees": [],
        "display": "Merve A. Türk",
        "group": false
      }
    ],
    "references_text": [
      "The International Association for the Study of Lung Cancer lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer\n\t\t\n\t\t\tHAsamura\n\t\t\n\t\t\n\t\t\tKChansky\n\t\t\n\t\t\n\t\t\tJCrowley\n\t\t\n\t\n\t\n\t\tJ Thorac Oncol\n\t\t\n\t\t\t10\n\t\t\t\n\t\t\t2015",
      "Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer\n\t\t\n\t\t\tJaeKwangYun\n\t\t\t0000-0001-5364-5548\n\t\t\n\t\t\n\t\t\tGeunDongLee\n\t\t\t0000-0003-1890-7455\n\t\t\n\t\t\n\t\t\tSehoonChoi\n\t\t\t0000-0002-9961-9289\n\t\t\n\t\t\n\t\t\tHyeongRyulKim\n\t\t\t0000-0002-6691-7693\n\t\t\n\t\t\n\t\t\tYong-HeeKim\n\t\t\t0000-0003-2177-4876\n\t\t\n\t\t\n\t\t\tDongKwanKim\n\t\t\t0000-0003-1984-0352\n\t\t\n\t\t\n\t\t\tSeung-IlPark\n\t\t\t0000-0002-8729-0498\n\t\t\n\t\t10.1093/ejcts/ezz147\n\t\n\t\n\t\tEuropean Journal of Cardio-Thoracic Surgery\n\t\t1010-7940\n\t\t1873-734X\n\t\t\n\t\t\t56\n\t\t\t5\n\t\t\t\n\t\t\t2019\n\t\t\tOxford University Press (OUP)",
      "Recommended Change in the N Descriptor Proposed by the International Association for the Study of Lung Cancer: A Validation Study\n\t\t\n\t\t\tByungJoPark\n\t\t\n\t\t\n\t\t\tTaeHoKim\n\t\t\n\t\t\n\t\t\tSuminShin\n\t\t\n\t\t\n\t\t\tHongKwanKim\n\t\t\n\t\t\n\t\t\tYongSooChoi\n\t\t\n\t\t\n\t\t\tJhingookKim\n\t\t\n\t\t\n\t\t\tJaeIllZo\n\t\t\n\t\t\n\t\t\tYoungMogShim\n\t\t\n\t\t\n\t\t\tJongHoCho\n\t\t\n\t\t10.1016/j.jtho.2019.07.034\n\t\n\t\n\t\tJournal of Thoracic Oncology\n\t\tJournal of Thoracic Oncology\n\t\t1556-0864\n\t\t\n\t\t\t14\n\t\t\t11\n\t\t\t\n\t\t\t2019\n\t\t\tElsevier BV",
      "The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the N Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer\n\t\t\n\t\t\tJamesHuang\n\t\t\n\t\t\n\t\t\tRaymondUOsarogiagbon\n\t\t\n\t\t\n\t\t\tDorothyJGiroux\n\t\t\n\t\t\n\t\t\tKatherineKNishimura\n\t\t\n\t\t\n\t\t\tAndreaBille\n\t\t\n\t\t\n\t\t\tGiuseppeCardillo\n\t\t\n\t\t\n\t\t\tFrankDetterbeck\n\t\t\n\t\t\n\t\t\tKempKernstine\n\t\t\n\t\t\n\t\t\tHongKwanKim\n\t\t\n\t\t\n\t\t\tYolandeLievens\n\t\t\n\t\t\n\t\t\tEricLim\n\t\t\n\t\t\n\t\t\tEdithMarom\n\t\t\n\t\t\n\t\t\tHelmutProsch\n\t\t\n\t\t\n\t\t\tPaulMartinPutora\n\t\t\n\t\t\n\t\t\tRamonRami-Porta\n\t\t\n\t\t\n\t\t\tDavidRice\n\t\t\n\t\t\n\t\t\tGaetanoRocco\n\t\t\n\t\t\n\t\t\tValerieWRusch\n\t\t\n\t\t\n\t\t\tIsabelleOpitz\n\t\t\n\t\t\n\t\t\tFranciscoSuarezVasquez\n\t\t\n\t\t\n\t\t\tPaulVan Schil\n\t\t\n\t\t\n\t\t\tChi-FuJeffrey Yang\n\t\t\n\t\t\n\t\t\tHisaoAsamura\n\t\t\n\t\t10.1016/j.jtho.2023.10.012\n\t\n\t\n\t\tJournal of Thoracic Oncology\n\t\tJournal of Thoracic Oncology\n\t\t1556-0864\n\t\t\n\t\t\t19\n\t\t\t5\n\t\t\t\n\t\t\t2024\n\t\t\tElsevier BV",
      "Validation Study for the N Descriptor of the Newly Proposed Ninth Edition of the TNM Staging System Proposed by the International Association for the Study of Lung Cancer\n\t\t\n\t\t\tInHaKim\n\t\t\t0000-0002-8084-0573\n\t\t\n\t\t\n\t\t\tGeunDongLee\n\t\t\n\t\t\n\t\t\tSehoonChoi\n\t\t\n\t\t\n\t\t\tHyeongRyulKim\n\t\t\n\t\t\n\t\t\tYong-HeeKim\n\t\t\n\t\t\n\t\t\tDongKwanKim\n\t\t\n\t\t\n\t\t\tSeung-IlPark\n\t\t\n\t\t\n\t\t\tJaeKwangYun\n\t\t\t0000-0001-5364-5548\n\t\t\n\t\t10.1016/j.jtho.2024.04.002\n\t\n\t\n\t\tJournal of Thoracic Oncology\n\t\tJournal of Thoracic Oncology\n\t\t1556-0864\n\t\t\n\t\t\t19\n\t\t\t8\n\t\t\t\n\t\t\t2024\n\t\t\tElsevier BV",
      "Impact on Disease-Free Survival of Adjuvant Erlotinib or Gefitinib in Patients with Resected Lung Adenocarcinomas that Harbor EGFR Mutations\n\t\t\n\t\t\tYelenaYJanjigian\n\t\t\n\t\t\n\t\t\tBernardJPark\n\t\t\n\t\t\n\t\t\tMaureenFZakowski\n\t\t\n\t\t\n\t\t\tMarcLadanyi\n\t\t\n\t\t\n\t\t\tWilliamPao\n\t\t\n\t\t\n\t\t\tSandraPD'angelo\n\t\t\n\t\t\n\t\t\tMarkGKris\n\t\t\n\t\t\n\t\t\tRonglaiShen\n\t\t\n\t\t\n\t\t\tJuntingZheng\n\t\t\n\t\t\n\t\t\tChristopherGAzzoli\n\t\t\n\t\t10.1097/jto.0b013e318202bffe\n\t\n\t\n\t\tJournal of Thoracic Oncology\n\t\tJournal of Thoracic Oncology\n\t\t1556-0864\n\t\t\n\t\t\t6\n\t\t\t3\n\t\t\t\n\t\t\t2011\n\t\t\tElsevier BV",
      "Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer\n\t\t\n\t\t\tPatrickMForde\n\t\t\n\t\t\n\t\t\tJonathanSpicer\n\t\t\n\t\t\n\t\t\tShunLu\n\t\t\n\t\t\n\t\t\tMarianoProvencio\n\t\t\n\t\t\n\t\t\tTetsuyaMitsudomi\n\t\t\n\t\t\n\t\t\tMarkMAwad\n\t\t\n\t\t\n\t\t\tEnriquetaFelip\n\t\t\n\t\t\n\t\t\tStephenRBroderick\n\t\t\n\t\t\n\t\t\tJulieRBrahmer\n\t\t\n\t\t\n\t\t\tScottJSwanson\n\t\t\n\t\t\n\t\t\tKeithKerr\n\t\t\n\t\t\n\t\t\tChangliWang\n\t\t\n\t\t\n\t\t\tTudor-EliadeCiuleanu\n\t\t\n\t\t\n\t\t\tGeneBSaylors\n\t\t\n\t\t\n\t\t\tFumihiroTanaka\n\t\t\n\t\t\n\t\t\tHiroyukiIto\n\t\t\n\t\t\n\t\t\tKe-NengChen\n\t\t\n\t\t\n\t\t\tMoisheLiberman\n\t\t\n\t\t\n\t\t\tEverettEVokes\n\t\t\n\t\t\n\t\t\tJanisMTaube\n\t\t\n\t\t\n\t\t\tCecileDorange\n\t\t\n\t\t\n\t\t\tJunliangCai\n\t\t\n\t\t\n\t\t\tJosephFiore\n\t\t\n\t\t\n\t\t\tAnthonyJarkowski\n\t\t\n\t\t\n\t\t\tDavidBalli\n\t\t\n\t\t\n\t\t\tMarkSausen\n\t\t\n\t\t\n\t\t\tDimplePandya\n\t\t\n\t\t\n\t\t\tChristopheYCalvet\n\t\t\n\t\t\n\t\t\tNicolasGirard\n\t\t\n\t\t10.1056/nejmoa2202170\n\t\n\t\n\t\tNew England Journal of Medicine\n\t\tN Engl J Med\n\t\t0028-4793\n\t\t1533-4406\n\t\t\n\t\t\t386\n\t\t\t21\n\t\t\t\n\t\t\t2022\n\t\t\tMassachusetts Medical Society",
      "Objective Review of Mediastinal Lymph Node Examination in a Lung Cancer Resection Cohort\n\t\t\n\t\t\tRaymondUOsarogiagbon\n\t\t\n\t\t\n\t\t\tJeffreyWAllen\n\t\t\n\t\t\n\t\t\tAamerFarooq\n\t\t\n\t\t\n\t\t\tJamesTWu\n\t\t\n\t\t10.1097/jto.0b013e31823e5e2d\n\t\n\t\n\t\tJournal of Thoracic Oncology\n\t\tJournal of Thoracic Oncology\n\t\t1556-0864\n\t\t\n\t\t\t7\n\t\t\t2\n\t\t\t\n\t\t\t2012\n\t\t\tElsevier BV",
      "Incomplete Intrapulmonary Lymph Node Retrieval After Routine Pathologic Examination of Resected Lung Cancer\n\t\t\n\t\t\tRobertARamirez\n\t\t\n\t\t\n\t\t\tChristopherGWang\n\t\t\n\t\t\n\t\t\tLauraEMiller\n\t\t\n\t\t\n\t\t\tCourtneyAAdair\n\t\t\n\t\t\n\t\t\tAllenBerry\n\t\t\n\t\t\n\t\t\tXinhuaYu\n\t\t\n\t\t\n\t\t\tThomasFO'brien\n\t\t\n\t\t\n\t\t\tRaymondUOsarogiagbon\n\t\t\n\t\t10.1200/jco.2011.39.2589\n\t\n\t\n\t\tJournal of Clinical Oncology\n\t\tJCO\n\t\t0732-183X\n\t\t1527-7755\n\t\t\n\t\t\t30\n\t\t\t23\n\t\t\t\n\t\t\t2012\n\t\t\tAmerican Society of Clinical Oncology (ASCO)",
      "ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer☆\n\t\t\n\t\t\tDLardinois\n\t\t\n\t\t\n\t\t\tPDeleyn\n\t\t\n\t\t\n\t\t\tPVanschil\n\t\t\n\t\t\n\t\t\tRPorta\n\t\t\n\t\t\n\t\t\tDWaller\n\t\t\n\t\t\n\t\t\tBPasslick\n\t\t\n\t\t\n\t\t\tMZielinski\n\t\t\n\t\t\n\t\t\tKJunker\n\t\t\n\t\t\n\t\t\tERendina\n\t\t\n\t\t\n\t\t\tHRis\n\t\t\n\t\t10.1016/j.ejcts.2006.08.008\n\t\n\t\n\t\tEuropean Journal of Cardio-Thoracic Surgery\n\t\tEuropean Journal of Cardio-Thoracic Surgery\n\t\t1010-7940\n\t\t\n\t\t\t30\n\t\t\t5\n\t\t\t\n\t\t\t2006\n\t\t\tOxford University Press (OUP)"
    ],
    "references_raw": [
      "The International Association for the Study of Lung Cancer lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer\n\t\t\n\t\t\tHAsamura\n\t\t\n\t\t\n\t\t\tKChansky\n\t\t\n\t\t\n\t\t\tJCrowley\n\t\t\n\t\n\t\n\t\tJ Thorac Oncol\n\t\t\n\t\t\t10\n\t\t\t\n\t\t\t2015",
      "Comparison between lymph node station-and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer\n\t\t\n\t\t\tJKYun\n\t\t\n\t\t\n\t\t\tGDLee\n\t\t\n\t\t\n\t\t\tSChoi\n\t\t\n\t\n\t\n\t\tEur J Cardiothorac Surg\n\t\t\n\t\t\t56\n\t\t\t\n\t\t\t2019",
      "Recommended change in the N descriptor proposed by the International Association for the Study of Lung Cancer: a validation study\n\t\t\n\t\t\tBJPark\n\t\t\n\t\t\n\t\t\tTHKim\n\t\t\n\t\t\n\t\t\tSShin\n\t\t\n\t\n\t\n\t\tJ Thorac Oncol\n\t\t\n\t\t\t14\n\t\t\t\n\t\t\t2019",
      "The International Association for the Study of Lung Cancer staging project for lung cancer: proposals for the revision of the N descriptors in the forthcoming ninth edition of the TNM classification for lung cancer\n\t\t\n\t\t\tJHuang\n\t\t\n\t\t\n\t\t\tRUOsarogiagbon\n\t\t\n\t\t\n\t\t\tDJGiroux\n\t\t\n\t\n\t\n\t\tJ Thorac Oncol\n\t\t\n\t\t\t19\n\t\t\t\n\t\t\t2024",
      "Validation study for the N descriptor of the newly proposed ninth edition of the TNM staging system proposed by the International Association for the study of lung cancer\n\t\t\n\t\t\tIHKim\n\t\t\n\t\t\n\t\t\tGDLee\n\t\t\n\t\t\n\t\t\tSChoi\n\t\t\n\t\n\t\n\t\tJ Thorac Oncol\n\t\t\n\t\t\t19\n\t\t\t\n\t\t\t2024",
      "Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations\n\t\t\n\t\t\tYYJanjigian\n\t\t\n\t\t\n\t\t\tBJPark\n\t\t\n\t\t\n\t\t\tMFZakowski\n\t\t\n\t\n\t\n\t\tJ Thorac Oncol\n\t\t\n\t\t\t6\n\t\t\t\n\t\t\t2011",
      "Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer\n\t\t\n\t\t\tPMForde\n\t\t\n\t\t\n\t\t\tJSpicer\n\t\t\n\t\t\n\t\t\tSLu\n\t\t\n\t\n\t\n\t\tN Engl J Med\n\t\t\n\t\t\t386\n\t\t\t\n\t\t\t2022",
      "Objective review of mediastinal lymph node examination in a lung cancer resection cohort\n\t\t\n\t\t\tRUOsarogiagbon\n\t\t\n\t\t\n\t\t\tJWAllen\n\t\t\n\t\t\n\t\t\tAFarooq\n\t\t\n\t\t\n\t\t\tJTWu\n\t\t\n\t\n\t\n\t\tJ Thorac Oncol\n\t\t\n\t\t\t7\n\t\t\t\n\t\t\t2012",
      "Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer\n\t\t\n\t\t\tRARamirez\n\t\t\n\t\t\n\t\t\tCGWang\n\t\t\n\t\t\n\t\t\tLEMiller\n\t\t\n\t\n\t\n\t\tJ Clin Oncol\n\t\t\n\t\t\t30\n\t\t\t\n\t\t\t2012",
      "ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer\n\t\t\n\t\t\tDLardinois\n\t\t\n\t\t\n\t\t\tPDe Leyn\n\t\t\n\t\t\n\t\t\tVanSchil\n\t\t\n\t\t\n\t\t\tP\n\t\t\n\t\n\t\n\t\tEur J Cardiothorac Surg\n\t\t\n\t\t\t30\n\t\t\t\n\t\t\t2006"
    ],
    "references_struct": [
      {
        "title": "The International Association for the Study of Lung Cancer lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer",
        "journal": "J Thorac Oncol",
        "year": "2015",
        "volume": "10",
        "issue": null,
        "pages": null,
        "doi": null,
        "pmid": null,
        "authors": [
          "Asamura H",
          "Chansky K",
          "Crowley J"
        ],
        "first_author_last": "Asamura"
      },
      {
        "title": "Comparison between lymph node station-and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer",
        "journal": "Eur J Cardiothorac Surg",
        "year": "2019",
        "volume": "56",
        "issue": null,
        "pages": null,
        "doi": null,
        "pmid": null,
        "authors": [
          "Yun JK",
          "Lee GD",
          "Choi S"
        ],
        "first_author_last": "Yun"
      },
      {
        "title": "Recommended change in the N descriptor proposed by the International Association for the Study of Lung Cancer: a validation study",
        "journal": "J Thorac Oncol",
        "year": "2019",
        "volume": "14",
        "issue": null,
        "pages": null,
        "doi": null,
        "pmid": null,
        "authors": [
          "Park BJ",
          "Kim TH",
          "Shin S"
        ],
        "first_author_last": "Park"
      },
      {
        "title": "The International Association for the Study of Lung Cancer staging project for lung cancer: proposals for the revision of the N descriptors in the forthcoming ninth edition of the TNM classification for lung cancer",
        "journal": "J Thorac Oncol",
        "year": "2024",
        "volume": "19",
        "issue": null,
        "pages": null,
        "doi": null,
        "pmid": null,
        "authors": [
          "Huang J",
          "Osarogiagbon RU",
          "Giroux DJ"
        ],
        "first_author_last": "Huang"
      },
      {
        "title": "Validation study for the N descriptor of the newly proposed ninth edition of the TNM staging system proposed by the International Association for the study of lung cancer",
        "journal": "J Thorac Oncol",
        "year": "2024",
        "volume": "19",
        "issue": null,
        "pages": null,
        "doi": null,
        "pmid": null,
        "authors": [
          "Kim IH",
          "Lee GD",
          "Choi S"
        ],
        "first_author_last": "Kim"
      },
      {
        "title": "Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations",
        "journal": "J Thorac Oncol",
        "year": "2011",
        "volume": "6",
        "issue": null,
        "pages": null,
        "doi": null,
        "pmid": null,
        "authors": [
          "Janjigian YY",
          "Park BJ",
          "Zakowski MF"
        ],
        "first_author_last": "Janjigian"
      },
      {
        "title": "Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer",
        "journal": "N Engl J Med",
        "year": "2022",
        "volume": "386",
        "issue": null,
        "pages": null,
        "doi": null,
        "pmid": null,
        "authors": [
          "Forde PM",
          "Spicer J",
          "Lu S"
        ],
        "first_author_last": "Forde"
      },
      {
        "title": "Objective review of mediastinal lymph node examination in a lung cancer resection cohort",
        "journal": "J Thorac Oncol",
        "year": "2012",
        "volume": "7",
        "issue": null,
        "pages": null,
        "doi": null,
        "pmid": null,
        "authors": [
          "Osarogiagbon RU",
          "Allen JW",
          "Farooq A",
          "Wu JT"
        ],
        "first_author_last": "Osarogiagbon"
      },
      {
        "title": "Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer",
        "journal": "J Clin Oncol",
        "year": "2012",
        "volume": "30",
        "issue": null,
        "pages": null,
        "doi": null,
        "pmid": null,
        "authors": [
          "Ramirez RA",
          "Wang CG",
          "Miller LE"
        ],
        "first_author_last": "Ramirez"
      },
      {
        "title": "ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer",
        "journal": "Eur J Cardiothorac Surg",
        "year": "2006",
        "volume": "30",
        "issue": null,
        "pages": null,
        "doi": null,
        "pmid": null,
        "authors": [
          "Lardinois D",
          "De Leyn P",
          "Schil V",
          "P"
        ],
        "first_author_last": "Lardinois"
      }
    ],
    "references_enriched": [
      {
        "title": "The International Association for the Study of Lung Cancer lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer"
      },
      {
        "title": "J Thorac Oncol",
        "year": 2015
      },
      {
        "title": "Comparison between lymph node station-and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer",
        "year": 2015
      },
      {
        "title": "Eur J Cardiothorac Surg",
        "year": 2019
      },
      {
        "title": "Recommended change in the N descriptor proposed by the International Association for the Study of Lung Cancer: a validation study",
        "year": 2019
      },
      {
        "title": "J Thorac Oncol",
        "year": 2015
      },
      {
        "title": "The International Association for the Study of Lung Cancer staging project for lung cancer: proposals for the revision of the N descriptors in the forthcoming ninth edition of the TNM classification for lung cancer",
        "year": 2019
      },
      {
        "title": "J Thorac Oncol",
        "year": 2015
      },
      {
        "title": "Validation study for the N descriptor of the newly proposed ninth edition of the TNM staging system proposed by the International Association for the study of lung cancer",
        "year": 2024
      },
      {
        "title": "J Thorac Oncol",
        "year": 2015
      },
      {
        "title": "Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations",
        "year": 2024
      },
      {
        "title": "J Thorac Oncol",
        "year": 2015
      },
      {
        "title": "Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer",
        "year": 2011
      },
      {
        "title": "N Engl J Med",
        "year": 2022
      },
      {
        "title": "Objective review of mediastinal lymph node examination in a lung cancer resection cohort",
        "year": 2022
      },
      {
        "title": "J Thorac Oncol",
        "year": 2015
      },
      {
        "title": "Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer",
        "year": 2012
      },
      {
        "title": "J Clin Oncol",
        "year": 2012
      },
      {
        "title": "ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer",
        "year": 2012
      },
      {
        "title": "Eur J Cardiothorac Surg",
        "year": 2019
      }
    ],
    "references_source": "grobid_fallback",
    "year_norm": "2024",
    "doi": "10.1016/j.jtho.2024.06.003",
    "journal": "Journal of Thoracic Oncology",
    "volume": "19",
    "issue": "8",
    "pages": "1133-1134",
    "issn": "15560864",
    "url": "https://linkinghub.elsevier.com/retrieve/pii/S1556086424006130",
    "published": {
      "print": null,
      "online": "2024-08"
    },
    "journal_full": "Journal of Thoracic Oncology"
  },
  "structure": {
    "sections": [
      {
        "title": "Editorial Comment: Validation Study for the N Descriptor of the Newly Proposed 9th Edition of the TNM Staging System Proposed by the International Association for the Study of Lung Cancer",
        "paragraphs": [
          {
            "text": "Merve A. Türk, MD*"
          },
          {
            "text": "The cancer staging is a triple component of tumor size (T), lymph node involvement (N), and the presence of metastases (M). The TNM system has undergone several revisions in lung cancer staging, and the latest TNM 8th edition has been in use worldwide since 2017. The N stage of 8th staging is based on the anatomical location of nodal metastases rather than the number of metastasized lymph nodes. The location-based classi /uniFB01 cation does not re /uniFB02 ect tumor burden in regional lymph nodes. To demonstrate prognostic heterogeneity, it has been emphasized that factors other than anatomical elements of lymph nodes are also effective and that lymph nodes should be reclassi /uniFB01 ed into subgroups. 1 -3 The objectives were to eliminate heterogeneity in the planned classi /uniFB01 -cation, to be applicable in clinical practice, and to have a clinical presentation of the new classi /uniFB01 cation. 4"
          },
          {
            "text": "The recent publication by Kim et al. 5 in a large series, not only focused on overall survival (OS) and recurrence-free survival (RFS) at the clinical and pathological N stage of the N descriptor but also analyzed other survival factors that affect OS and RFS in lung cancer. According to age, gender, histology, comorbid diseases, and year of surgery, models were created, and 5-year survival differences were demonstrated in the N classi /uniFB01 cation, except for the T4 group. However, it is known that EGFR mutations are the most common oncogenic factor in lung adenocarcinoma in neversmokers in East Asia. The detection of mutation analysis in Non-small cell lung cancer (NSCLC) and appropriate treatments in this patient group have shown signi /uniFB01 cant differences in survival. The study by Janjigian et al 6 demonstrated the disease-free survival effect of adjuvant erlotinib in resected stage IA -IIIA patients. The use of mutation analyses was not widespread at the time the database was created in the study by Kim et al. 5 Therefore, a confounder in OS and RFS was known but could not be used in the analyses. Mutation analyses may be added to the database developed for the TNM staging system in future studies. The"
          },
          {
            "text": "impact of genetic mutation analysis, which is an important determinant of Non-small cell lung cancer (NSCLC) prognosis, on the N factor in staging remains important."
          },
          {
            "text": "The differentiation of the N descriptor into single N (N2a) and multiple N (N2b) was shown in the study to balance the heterogeneity in staging and to provide a clearer distinction in all categories. 5 A comparison was also made with the staging proposed by Asamura et al. 1 where, due to the small sample size, an overlap between the survival curves was observed. In the study by Kim et al, 5 a speci /uniFB01 c group of patients who underwent surgical resection and did not receive neoadjuvant therapy was included, to show how the results would be in the heterogeneity of the whole world. However, Huang et al. 4 obtained similar results to the present study with data from a larger population in a study to validate the current N classi /uniFB01 cation for the ninth edition of the staging system and revision of the categories to include nodal metastasis burden. In the clinical implications of these results, the importance of distinguishing between N2a and N2b is emphasized, as it could potentially allow for different therapeutic approaches. As the use of immunotherapy has become widespread, favorable"
          },
          {
            "text": "*Corresponding author."
          },
          {
            "text": "Department of Pulmonology, _ Izmir Bozyaka Training and Research Hospital, Izmir, Turkey"
          },
          {
            "text": "Address for correspondence: Merve Ayik Türk, MD, Department of Pulmonology, _ Izmir Bozyaka Training and Research Hospital, 286/3 St. No:17 _ Izmir 35353, Turkey. E-mail: merve.ayik@hotmail.com"
          },
          {
            "text": "Cite this article as: Türk MA. Editorial comment: validation study for the N descriptor of the newly proposed 9th edition of the TNM staging system proposed by the International Association for the Study of Lung Cancer. J Thorac Oncol 2024;19:1133-1134"
          },
          {
            "text": "ª 2024 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies."
          },
          {
            "text": "ISSN: 1556-0864"
          },
          {
            "text": "https://doi.org/10.1016/j.jtho.2024.06.003"
          },
          {
            "text": "postoperative survival data have been obtained in N2 disease with neoadjuvant treatments. 7 The de /uniFB01 nition of N2a or N2b disease will have a clinical contribution in order to determine the de /uniFB01 nition of operability in N2 disease and to provide clear evidence in which patient group surgery may be a treatment option. In this sense, the fact that the study population includes a special group is considered to be in line with the clinical presentation of staging."
          },
          {
            "text": "Unlike N1 stations, which are dif /uniFB01 cult to distinguish in clinical staging, the division of N2 lymph nodes into single and multiple stations will be easier to implement with radiologic developments and the widespread use of positron emission tomography/computed tomography. However, it is thought that there may be dif /uniFB01 culties in N2a or N2b differentiation in suspicious lymph nodes that are more dif /uniFB01 cult to access in patients who need invasive clinical staging. The classi /uniFB01 cation of lymph nodes at the boundary of anatomical location, even in the anatomical N descriptor, has weaknesses as it may involve the subjective decisions of surgeons or pathologists. 8,9 Despite the widespread use of positron emission tomography/computed tomography and endobronchial ultrasound or transesophageal ultrasound providing convenience in terms of mediastinal staging, it is thought that there may be dif /uniFB01 culties in N2a/N2b differentiation, especially in invasive mediastinal staging after treatments such as chemoimmunotherapy, especially in interventional procedures. It will also need a systematic approach to the evaluation of lymph nodes with experience in invasive mediastinal staging and N2a or N2b differentiation."
          },
          {
            "text": "The method used to evaluate the lymph nodes collected in invasive mediastinal staging also needs to be standardized. In the study, 5 there was a standardized lymph node assessment from a single center. However, it is known that incomplete removal of lymph nodes seriously affects nodal categorization. 9 Since this may change the pathological N results, the importance of standardized methods should be emphasized. 10 Furthermore, the differences in survival outcomes are clearly emphasized in the numerical distinction of lymph nodes in the pathological N stage, but the effect of factors such as lymph node ratio, size, and extracapsular distribution on the stage is not known."
          },
          {
            "text": "In the study by Kim et al. 5 which emphasized the important results of the single/multiple N2 distinction and included the effective variables on OS/RFS in the analysis, it was shown that the distinction between N2a or N2b provides a more homogeneous distribution in staging. Demonstrating the difference in N involvement in staging is thought to provide new treatment approaches with the developments in treatment options in Non-small cell lung cancer (NSCLC). However, it still arouses curiosity to what extent"
          },
          {
            "text": "this staging will have a clear clinical contribution and how applicable it will be to clinicians."
          }
        ],
        "category": "other"
      },
      {
        "title": "CRediT Authorship Contribution Statement",
        "paragraphs": [
          {
            "text": "Merve A. Türk: Conceptualization, Investigation, Methodology, Project administration, Resources, Software, Writing -original draft, Writing -review and editing."
          }
        ],
        "category": "other"
      },
      {
        "title": "Disclosure",
        "paragraphs": [
          {
            "text": "The author declares no con /uniFB02 ict of interest."
          }
        ],
        "category": "other"
      },
      {
        "title": "References",
        "paragraphs": [
          {
            "text": "1. Asamura H, Chansky K, Crowley J, et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classi /uniFB01 cation for lung cancer. J Thorac Oncol . 2015;10:1675 -1684."
          },
          {
            "text": "2. Yun JK, Lee GD, Choi S, et al. Comparison between lymph node station- and zone-based classi /uniFB01 cation for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer. Eur J Cardiothorac Surg . 2019;56:849 -857."
          },
          {
            "text": "3. Park BJ, Kim TH, Shin S, et al. Recommended change in the N descriptor proposed by the International Association for the Study of Lung Cancer: a validation study. J Thorac Oncol . 2019;14:1962 -1969."
          },
          {
            "text": "4. Huang J, Osarogiagbon RU, Giroux DJ, et al. The International Association for the Study of Lung Cancer staging project for lung cancer: proposals for the revision of the N descriptors in the forthcoming ninth edition of the TNM classi /uniFB01 cation for lung cancer. J Thorac Oncol . 2024;19:766 -785."
          },
          {
            "text": "5. Kim IH, Lee GD, Choi S, et al. Validation study for the N descriptor of the newly proposed ninth edition of the TNM staging system proposed by the International Association for the study of lung cancer. J Thorac Oncol . 2024;19:1218 -1227."
          },
          {
            "text": "6. Janjigian YY, Park BJ, Zakowski MF, et al. Impact on disease-free survival of adjuvant erlotinib or ge /uniFB01 tinib in patients with resected lung adenocarcinomas that harbor EGFR mutations. J Thorac Oncol . 2011;6:569 -575."
          },
          {
            "text": "7. Forde PM, Spicer J, Lu S, et al. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med . 2022;386:1973 -1985."
          },
          {
            "text": "8. Osarogiagbon RU, Allen JW, Farooq A, Wu JT. Objective review of mediastinal lymph node examination in a lung cancer resection cohort. J Thorac Oncol . 2012;7:390 -396."
          },
          {
            "text": "9. Ramirez RA, Wang CG, Miller LE, et al. Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer. J Clin Oncol . 2012;30:2823 -2828."
          },
          {
            "text": "10. Lardinois D, De Leyn P , Van Schil P , et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg . 2006;30:787 -792."
          }
        ],
        "category": "other"
      }
    ],
    "tables": [],
    "figures": [
      {
        "self_ref": "#/pictures/0",
        "parent": {
          "cref": "#/body"
        },
        "children": [],
        "content_layer": "body",
        "label": "picture",
        "prov": [
          {
            "page_no": 1,
            "bbox": {
              "l": 498.0604248046875,
              "t": 729.2449798583984,
              "r": 538.5850830078125,
              "b": 699.0818634033203,
              "coord_origin": "BOTTOMLEFT"
            },
            "charspan": [
              0,
              0
            ]
          }
        ],
        "captions": [],
        "references": [],
        "footnotes": [],
        "image": null,
        "annotations": []
      },
      {
        "self_ref": "#/pictures/1",
        "parent": {
          "cref": "#/body"
        },
        "children": [],
        "content_layer": "body",
        "label": "picture",
        "prov": [
          {
            "page_no": 1,
            "bbox": {
              "l": 459.5768737792969,
              "t": 678.8507995605469,
              "r": 539.0109252929688,
              "b": 662.1413650512695,
              "coord_origin": "BOTTOMLEFT"
            },
            "charspan": [
              0,
              0
            ]
          }
        ],
        "captions": [],
        "references": [],
        "footnotes": [],
        "image": null,
        "annotations": []
      }
    ],
    "citations": [],
    "n_sections": 4,
    "n_tables": 0,
    "n_figures": 2,
    "n_citations": 0
  },
  "provenance": {
    "patches": [
      {
        "path": "metadata.year_norm",
        "op": "set",
        "from": null,
        "to": "2024",
        "source": "zotero:year_norm",
        "confidence": 0.9
      },
      {
        "path": "metadata.authors",
        "op": "set",
        "from": [
          "East Asia",
          "Izmir Bozyaka Training"
        ],
        "to": [
          "Merve A. Türk"
        ],
        "source": "zotero:authors",
        "confidence": 0.9
      },
      {
        "path": "metadata.doi",
        "op": "set",
        "from": null,
        "to": "10.1016/j.jtho.2024.06.003",
        "source": "zotero:doi",
        "confidence": 0.9
      },
      {
        "path": "metadata.journal",
        "op": "set",
        "from": null,
        "to": "Journal of Thoracic Oncology",
        "source": "zotero:journal",
        "confidence": 0.9
      },
      {
        "path": "metadata.volume",
        "op": "set",
        "from": null,
        "to": "19",
        "source": "zotero:volume",
        "confidence": 0.9
      },
      {
        "path": "metadata.issue",
        "op": "set",
        "from": null,
        "to": "8",
        "source": "zotero:issue",
        "confidence": 0.9
      },
      {
        "path": "metadata.pages",
        "op": "set",
        "from": null,
        "to": "1133-1134",
        "source": "zotero:pages",
        "confidence": 0.9
      },
      {
        "path": "metadata.issn",
        "op": "set",
        "from": null,
        "to": "15560864",
        "source": "zotero:issn",
        "confidence": 0.9
      },
      {
        "path": "metadata.url",
        "op": "set",
        "from": null,
        "to": "https://linkinghub.elsevier.com/retrieve/pii/S1556086424006130",
        "source": "zotero:url",
        "confidence": 0.9
      },
      {
        "path": "provenance.orig_pdf_filename",
        "op": "set",
        "from": null,
        "to": "Türk - 2024 - Editorial Comment Validation Study for the N Descriptor of the Newly Proposed 9th Edition of the TN.pdf",
        "source": "zotero:csv",
        "confidence": 0.9
      },
      {
        "path": "metadata.year",
        "op": "set",
        "from": "2024-08",
        "to": 2024,
        "source": "normalize:iso",
        "confidence": 0.9
      },
      {
        "path": "metadata.authors",
        "op": "set",
        "from": [
          "Merve A. Türk"
        ],
        "to": [
          {
            "given": "Merve A.",
            "family": "Türk",
            "suffix": null,
            "degrees": [],
            "display": "Merve A. Türk",
            "group": false
          }
        ],
        "source": "filtered_ack_like",
        "confidence": 0.9
      },
      {
        "path": "metadata.journal_full",
        "op": "set",
        "from": null,
        "to": "Journal of Thoracic Oncology",
        "source": "canonicalize",
        "confidence": 0.9
      }
    ],
    "orig_pdf_filename": "Türk - 2024 - Editorial Comment Validation Study for the N Descriptor of the Newly Proposed 9th Edition of the TN.pdf",
    "zotero": {
      "id": "turkEditorialCommentValidation2024",
      "source": "zotero_csl+csv",
      "exported_at": "2025-09-02T20:29:40.203189Z",
      "match_method": "title_exact",
      "match_confidence": 1.0
    }
  },
  "grobid": {
    "references_tei": "<TEI xmlns=\"http://www.tei-c.org/ns/1.0\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" \n xmlns:mml=\"http://www.w3.org/1998/Math/MathML\">\n\t<teiHeader/>\n\t<text>\n\t\t<front/>\n\t\t<body/>\n\t\t<back>\n\t\t\t<div>\n\t\t\t\t<listBibl>\n<biblStruct xml:id=\"b0\">\n\t<analytic>\n\t\t<title level=\"a\" type=\"main\">The International Association for the Study of Lung Cancer lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer</title>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">H</forename><surname>Asamura</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">K</forename><surname>Chansky</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">J</forename><surname>Crowley</surname></persName>\n\t\t</author>\n\t</analytic>\n\t<monogr>\n\t\t<title level=\"j\">J Thorac Oncol</title>\n\t\t<imprint>\n\t\t\t<biblScope unit=\"volume\">10</biblScope>\n\t\t\t<biblScope unit=\"page\" from=\"1675\" to=\"1684\" />\n\t\t\t<date type=\"published\" when=\"2015\">2015</date>\n\t\t</imprint>\n\t</monogr>\n</biblStruct>\n\n<biblStruct xml:id=\"b1\">\n\t<analytic>\n\t\t<title level=\"a\" type=\"main\">Comparison between lymph node station-and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer</title>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">J</forename><forename type=\"middle\">K</forename><surname>Yun</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">G</forename><forename type=\"middle\">D</forename><surname>Lee</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">S</forename><surname>Choi</surname></persName>\n\t\t</author>\n\t</analytic>\n\t<monogr>\n\t\t<title level=\"j\">Eur J Cardiothorac Surg</title>\n\t\t<imprint>\n\t\t\t<biblScope unit=\"volume\">56</biblScope>\n\t\t\t<biblScope unit=\"page\" from=\"849\" to=\"857\" />\n\t\t\t<date type=\"published\" when=\"2019\">2019</date>\n\t\t</imprint>\n\t</monogr>\n</biblStruct>\n\n<biblStruct xml:id=\"b2\">\n\t<analytic>\n\t\t<title level=\"a\" type=\"main\">Recommended change in the N descriptor proposed by the International Association for the Study of Lung Cancer: a validation study</title>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">B</forename><forename type=\"middle\">J</forename><surname>Park</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">T</forename><forename type=\"middle\">H</forename><surname>Kim</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">S</forename><surname>Shin</surname></persName>\n\t\t</author>\n\t</analytic>\n\t<monogr>\n\t\t<title level=\"j\">J Thorac Oncol</title>\n\t\t<imprint>\n\t\t\t<biblScope unit=\"volume\">14</biblScope>\n\t\t\t<biblScope unit=\"page\" from=\"1962\" to=\"1969\" />\n\t\t\t<date type=\"published\" when=\"2019\">2019</date>\n\t\t</imprint>\n\t</monogr>\n</biblStruct>\n\n<biblStruct xml:id=\"b3\">\n\t<analytic>\n\t\t<title level=\"a\" type=\"main\">The International Association for the Study of Lung Cancer staging project for lung cancer: proposals for the revision of the N descriptors in the forthcoming ninth edition of the TNM classification for lung cancer</title>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">J</forename><surname>Huang</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">R</forename><forename type=\"middle\">U</forename><surname>Osarogiagbon</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">D</forename><forename type=\"middle\">J</forename><surname>Giroux</surname></persName>\n\t\t</author>\n\t</analytic>\n\t<monogr>\n\t\t<title level=\"j\">J Thorac Oncol</title>\n\t\t<imprint>\n\t\t\t<biblScope unit=\"volume\">19</biblScope>\n\t\t\t<biblScope unit=\"page\" from=\"766\" to=\"785\" />\n\t\t\t<date type=\"published\" when=\"2024\">2024</date>\n\t\t</imprint>\n\t</monogr>\n</biblStruct>\n\n<biblStruct xml:id=\"b4\">\n\t<analytic>\n\t\t<title level=\"a\" type=\"main\">Validation study for the N descriptor of the newly proposed ninth edition of the TNM staging system proposed by the International Association for the study of lung cancer</title>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">I</forename><forename type=\"middle\">H</forename><surname>Kim</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">G</forename><forename type=\"middle\">D</forename><surname>Lee</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">S</forename><surname>Choi</surname></persName>\n\t\t</author>\n\t</analytic>\n\t<monogr>\n\t\t<title level=\"j\">J Thorac Oncol</title>\n\t\t<imprint>\n\t\t\t<biblScope unit=\"volume\">19</biblScope>\n\t\t\t<biblScope unit=\"page\" from=\"1218\" to=\"1227\" />\n\t\t\t<date type=\"published\" when=\"2024\">2024</date>\n\t\t</imprint>\n\t</monogr>\n</biblStruct>\n\n<biblStruct xml:id=\"b5\">\n\t<analytic>\n\t\t<title level=\"a\" type=\"main\">Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations</title>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">Y</forename><forename type=\"middle\">Y</forename><surname>Janjigian</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">B</forename><forename type=\"middle\">J</forename><surname>Park</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">M</forename><forename type=\"middle\">F</forename><surname>Zakowski</surname></persName>\n\t\t</author>\n\t</analytic>\n\t<monogr>\n\t\t<title level=\"j\">J Thorac Oncol</title>\n\t\t<imprint>\n\t\t\t<biblScope unit=\"volume\">6</biblScope>\n\t\t\t<biblScope unit=\"page\" from=\"569\" to=\"575\" />\n\t\t\t<date type=\"published\" when=\"2011\">2011</date>\n\t\t</imprint>\n\t</monogr>\n</biblStruct>\n\n<biblStruct xml:id=\"b6\">\n\t<analytic>\n\t\t<title level=\"a\" type=\"main\">Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer</title>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">P</forename><forename type=\"middle\">M</forename><surname>Forde</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">J</forename><surname>Spicer</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">S</forename><surname>Lu</surname></persName>\n\t\t</author>\n\t</analytic>\n\t<monogr>\n\t\t<title level=\"j\">N Engl J Med</title>\n\t\t<imprint>\n\t\t\t<biblScope unit=\"volume\">386</biblScope>\n\t\t\t<biblScope unit=\"page\" from=\"1973\" to=\"1985\" />\n\t\t\t<date type=\"published\" when=\"2022\">2022</date>\n\t\t</imprint>\n\t</monogr>\n</biblStruct>\n\n<biblStruct xml:id=\"b7\">\n\t<analytic>\n\t\t<title level=\"a\" type=\"main\">Objective review of mediastinal lymph node examination in a lung cancer resection cohort</title>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">R</forename><forename type=\"middle\">U</forename><surname>Osarogiagbon</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">J</forename><forename type=\"middle\">W</forename><surname>Allen</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">A</forename><surname>Farooq</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">J</forename><forename type=\"middle\">T</forename><surname>Wu</surname></persName>\n\t\t</author>\n\t</analytic>\n\t<monogr>\n\t\t<title level=\"j\">J Thorac Oncol</title>\n\t\t<imprint>\n\t\t\t<biblScope unit=\"volume\">7</biblScope>\n\t\t\t<biblScope unit=\"page\" from=\"390\" to=\"396\" />\n\t\t\t<date type=\"published\" when=\"2012\">2012</date>\n\t\t</imprint>\n\t</monogr>\n</biblStruct>\n\n<biblStruct xml:id=\"b8\">\n\t<analytic>\n\t\t<title level=\"a\" type=\"main\">Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer</title>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">R</forename><forename type=\"middle\">A</forename><surname>Ramirez</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">C</forename><forename type=\"middle\">G</forename><surname>Wang</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">L</forename><forename type=\"middle\">E</forename><surname>Miller</surname></persName>\n\t\t</author>\n\t</analytic>\n\t<monogr>\n\t\t<title level=\"j\">J Clin Oncol</title>\n\t\t<imprint>\n\t\t\t<biblScope unit=\"volume\">30</biblScope>\n\t\t\t<biblScope unit=\"page\" from=\"2823\" to=\"2828\" />\n\t\t\t<date type=\"published\" when=\"2012\">2012</date>\n\t\t</imprint>\n\t</monogr>\n</biblStruct>\n\n<biblStruct xml:id=\"b9\">\n\t<analytic>\n\t\t<title level=\"a\" type=\"main\">ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer</title>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">D</forename><surname>Lardinois</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">P</forename><surname>De Leyn</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">Van</forename><surname>Schil</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">P</forename></persName>\n\t\t</author>\n\t</analytic>\n\t<monogr>\n\t\t<title level=\"j\">Eur J Cardiothorac Surg</title>\n\t\t<imprint>\n\t\t\t<biblScope unit=\"volume\">30</biblScope>\n\t\t\t<biblScope unit=\"page\" from=\"787\" to=\"792\" />\n\t\t\t<date type=\"published\" when=\"2006\">2006</date>\n\t\t</imprint>\n\t</monogr>\n</biblStruct>\n\n\t\t\t\t</listBibl>\n\t\t\t</div>\n\t\t</back>\n\t</text>\n</TEI>\n"
  },
  "umls_links": [],
  "references_enriched": [
    {
      "title": "The International Association for the Study of Lung Cancer lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer",
      "journal": "J Thorac Oncol",
      "year": "2015",
      "volume": "10",
      "issue": null,
      "pages": null,
      "doi": null,
      "pmid": null,
      "authors": [
        "Asamura H",
        "Chansky K",
        "Crowley J"
      ],
      "first_author_last": "Asamura",
      "enrichment": {
        "pmid": null,
        "doi": null
      }
    },
    {
      "title": "Comparison between lymph node station-and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer",
      "journal": "Eur J Cardiothorac Surg",
      "year": "2019",
      "volume": "56",
      "issue": null,
      "pages": null,
      "doi": null,
      "pmid": null,
      "authors": [
        "Yun JK",
        "Lee GD",
        "Choi S"
      ],
      "first_author_last": "Yun",
      "enrichment": {
        "pmid": null,
        "doi": null
      }
    },
    {
      "title": "Recommended change in the N descriptor proposed by the International Association for the Study of Lung Cancer: a validation study",
      "journal": "J Thorac Oncol",
      "year": "2019",
      "volume": "14",
      "issue": null,
      "pages": null,
      "doi": null,
      "pmid": null,
      "authors": [
        "Park BJ",
        "Kim TH",
        "Shin S"
      ],
      "first_author_last": "Park",
      "enrichment": {
        "pmid": null,
        "doi": null
      }
    },
    {
      "title": "The International Association for the Study of Lung Cancer staging project for lung cancer: proposals for the revision of the N descriptors in the forthcoming ninth edition of the TNM classification for lung cancer",
      "journal": "J Thorac Oncol",
      "year": "2024",
      "volume": "19",
      "issue": null,
      "pages": null,
      "doi": null,
      "pmid": null,
      "authors": [
        "Huang J",
        "Osarogiagbon RU",
        "Giroux DJ"
      ],
      "first_author_last": "Huang",
      "enrichment": {
        "pmid": null,
        "doi": null
      }
    },
    {
      "title": "Validation study for the N descriptor of the newly proposed ninth edition of the TNM staging system proposed by the International Association for the study of lung cancer",
      "journal": "J Thorac Oncol",
      "year": "2024",
      "volume": "19",
      "issue": null,
      "pages": null,
      "doi": null,
      "pmid": null,
      "authors": [
        "Kim IH",
        "Lee GD",
        "Choi S"
      ],
      "first_author_last": "Kim",
      "enrichment": {
        "pmid": null,
        "doi": null
      }
    },
    {
      "title": "Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations",
      "journal": "J Thorac Oncol",
      "year": "2011",
      "volume": "6",
      "issue": null,
      "pages": null,
      "doi": null,
      "pmid": null,
      "authors": [
        "Janjigian YY",
        "Park BJ",
        "Zakowski MF"
      ],
      "first_author_last": "Janjigian",
      "enrichment": {
        "pmid": "21150674",
        "doi": null,
        "title": "Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations.",
        "journal": "Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer",
        "year": "2011",
        "authors": [
          "Janjigian YY",
          "Park BJ",
          "Zakowski MF",
          "Ladanyi M",
          "Pao W",
          "D'Angelo SP",
          "Kris MG",
          "Shen R",
          "Zheng J",
          "Azzoli CG"
        ],
        "mesh": [],
        "pubtypes": [
          "Journal Article"
        ],
        "abstract": "Patients with stage IV lung adenocarcinoma and epidermal growth factor receptor (EGFR) mutation derive clinical benefit from treatment with EGFR tyrosine kinase inhibitors (TKIs). Whether treatment with TKI improves outcomes in patients with resected lung adenocarcinoma and EGFR mutation is unknown."
      }
    },
    {
      "title": "Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer",
      "journal": "N Engl J Med",
      "year": "2022",
      "volume": "386",
      "issue": null,
      "pages": null,
      "doi": null,
      "pmid": null,
      "authors": [
        "Forde PM",
        "Spicer J",
        "Lu S"
      ],
      "first_author_last": "Forde",
      "enrichment": {
        "pmid": "35403841",
        "doi": null,
        "title": "Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.",
        "journal": "The New England journal of medicine",
        "year": "2022",
        "authors": [
          "Forde PM",
          "Spicer J",
          "Lu S",
          "Provencio M",
          "Mitsudomi T",
          "Awad MM",
          "Felip E",
          "Broderick SR",
          "Brahmer JR",
          "Swanson SJ",
          "Kerr K",
          "Wang C",
          "Ciuleanu TE",
          "Saylors GB",
          "Tanaka F",
          "Ito H",
          "Chen KN",
          "Liberman M",
          "Vokes EE",
          "Taube JM",
          "Dorange C",
          "Cai J",
          "Fiore J",
          "Jarkowski A",
          "Balli D",
          "Sausen M",
          "Pandya D",
          "Calvet CY",
          "Girard N",
          "CheckMate 816 Investigators"
        ],
        "mesh": [],
        "pubtypes": [
          "Journal Article",
          "Randomized Controlled Trial"
        ],
        "abstract": "Neoadjuvant or adjuvant chemotherapy confers a modest benefit over surgery alone for resectable non-small-cell lung cancer (NSCLC). In early-phase trials, nivolumab-based neoadjuvant regimens have shown promising clinical activity; however, data from phase 3 trials are needed to confirm these findings."
      }
    },
    {
      "title": "Objective review of mediastinal lymph node examination in a lung cancer resection cohort",
      "journal": "J Thorac Oncol",
      "year": "2012",
      "volume": "7",
      "issue": null,
      "pages": null,
      "doi": null,
      "pmid": null,
      "authors": [
        "Osarogiagbon RU",
        "Allen JW",
        "Farooq A",
        "Wu JT"
      ],
      "first_author_last": "Osarogiagbon",
      "enrichment": {
        "pmid": null,
        "doi": null
      }
    },
    {
      "title": "Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer",
      "journal": "J Clin Oncol",
      "year": "2012",
      "volume": "30",
      "issue": null,
      "pages": null,
      "doi": null,
      "pmid": null,
      "authors": [
        "Ramirez RA",
        "Wang CG",
        "Miller LE"
      ],
      "first_author_last": "Ramirez",
      "enrichment": {
        "pmid": "22778318",
        "doi": null,
        "title": "Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer.",
        "journal": "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
        "year": "2012",
        "authors": [
          "Ramirez RA",
          "Wang CG",
          "Miller LE",
          "Adair CA",
          "Berry A",
          "Yu X",
          "O'Brien TF",
          "Osarogiagbon RU"
        ],
        "mesh": [],
        "pubtypes": [
          "Journal Article"
        ],
        "abstract": "Pathologic nodal stage affects prognosis in patients with surgically resected non-small-cell lung cancer (NSCLC). Unlike examination of mediastinal lymph nodes (LNs), which depends on surgical practice, accurate examination of intrapulmonary (N1) nodes depends primarily on pathology practice. We investigated the completeness of N1 LN examination in NSCLC resection specimens and its potential impact on stage."
      }
    },
    {
      "title": "ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer",
      "journal": "Eur J Cardiothorac Surg",
      "year": "2006",
      "volume": "30",
      "issue": null,
      "pages": null,
      "doi": null,
      "pmid": null,
      "authors": [
        "Lardinois D",
        "De Leyn P",
        "Schil V",
        "P"
      ],
      "first_author_last": "Lardinois",
      "enrichment": {
        "pmid": "16971134",
        "doi": null,
        "title": "ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer.",
        "journal": "European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery",
        "year": "2006",
        "authors": [
          "Lardinois D",
          "De Leyn P",
          "Van Schil P",
          "Porta RR",
          "Waller D",
          "Passlick B",
          "Zielinski M",
          "Lerut T",
          "Weder W"
        ],
        "mesh": [],
        "pubtypes": [
          "Consensus Development Conference",
          "Journal Article",
          "Practice Guideline"
        ],
        "abstract": "The European Society of Thoracic Surgeons (ESTS) organized a workshop dealing with lymph node staging in non-small cell lung cancer. The objective of this workshop was to develop guidelines for definitions and the surgical procedures of intraoperative lymph node staging, and the pathologic evaluation of resected lymph nodes in patients with non-small cell lung cancer (NSCLC). Relevant peer-reviewed publications on the subjects, the experience of the participants, and the opinion of the ESTS members contributing on line, were used to reach a consensus. Systematic nodal dissection is recommended in all cases to ensure complete resection. Lobe-specific systematic nodal dissection is acceptable for peripheral squamous T1 tumors, if hilar and interlobar nodes are negative on frozen section studies; it implies removal of, at least, three hilar and interlobar nodes and three mediastinal nodes from three stations in which the subcarinal is always included. Selected lymph node biopsies and sampling are justified to prove nodal involvement when resection is not possible. Pathologic evaluation includes all lymph nodes resected separately and those remaining in the lung specimen. Sections are done at the site of gross abnormalities. If macroscopic inspection does not detect any abnormal site, 2-mm slices of the nodes in the longitudinal plane are recommended. Routine search for micrometastases or isolated tumor cells in hematoxylin-eosin negative nodes would be desirable. Randomized controlled trials to evaluate adjuvant therapies for patients with these conditions are recommended. The adherence to these guidelines will standardize the intraoperative lymph node staging and pathologic evaluation, and improve pathologic staging, which will help decide on the best adjuvant therapy."
      }
    }
  ],
  "drugs": [
    {
      "drug": "erlotinib",
      "dose": null,
      "span": [
        2005,
        2015
      ],
      "context": "isease-free survival effect of adjuvant erlotinib in resected stage IA -IIIA patients. The use of mutation analyses was not widesp"
    },
    {
      "drug": "erlotinib",
      "dose": null,
      "span": [
        9230,
        9240
      ],
      "context": "ct on disease-free survival of adjuvant erlotinib or ge /uniFB01 tinib in patients with resected lung adenocarcinomas that harbor "
    },
    {
      "drug": "nivolumab",
      "dose": null,
      "span": [
        9418,
        9428
      ],
      "context": " PM, Spicer J, Lu S, et al. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med . 2022;386:1973 -1985."
    }
  ],
  "trial_ids": [],
  "assets": {
    "tables": [],
    "figures": [
      {
        "type": "figure",
        "content": {
          "self_ref": "#/pictures/0",
          "parent": {
            "cref": "#/body"
          },
          "children": [],
          "content_layer": "body",
          "label": "picture",
          "prov": [
            {
              "page_no": 1,
              "bbox": {
                "l": 498.0604248046875,
                "t": 729.2449798583984,
                "r": 538.5850830078125,
                "b": 699.0818634033203,
                "coord_origin": "BOTTOMLEFT"
              },
              "charspan": [
                0,
                0
              ]
            }
          ],
          "captions": [],
          "references": [],
          "footnotes": [],
          "image": null,
          "annotations": []
        },
        "captions": [],
        "footnotes": [
          "mpact of genetic mutation analysis, which is an important determinant of Non-small cell lung cancer (NSCLC) prognosis, on the N factor in staging remains important.",
          "Corresponding author.",
          "ttps://doi.org/10.1016/j.jtho.2024.06.003",
          "ostoperative survival data have been obtained in N2 disease with neoadjuvant treatments. 7 The de /uniFB01 nition of N2a or N2b disease will have a clinical contribution in order to determine the de /uniFB01 nition of operability in N2 disease and to provide clear evidence in which patient group surgery may be a treatment option. In this sense, the fact that the study population includes a special group is considered to be in line with the clinical presentation of staging.",
          "his staging will have a clear clinical contribution and how applicable it will be to clinicians."
        ]
      },
      {
        "type": "figure",
        "content": {
          "self_ref": "#/pictures/1",
          "parent": {
            "cref": "#/body"
          },
          "children": [],
          "content_layer": "body",
          "label": "picture",
          "prov": [
            {
              "page_no": 1,
              "bbox": {
                "l": 459.5768737792969,
                "t": 678.8507995605469,
                "r": 539.0109252929688,
                "b": 662.1413650512695,
                "coord_origin": "BOTTOMLEFT"
              },
              "charspan": [
                0,
                0
              ]
            }
          ],
          "captions": [],
          "references": [],
          "footnotes": [],
          "image": null,
          "annotations": []
        },
        "captions": [],
        "footnotes": [
          "mpact of genetic mutation analysis, which is an important determinant of Non-small cell lung cancer (NSCLC) prognosis, on the N factor in staging remains important.",
          "Corresponding author.",
          "ttps://doi.org/10.1016/j.jtho.2024.06.003",
          "ostoperative survival data have been obtained in N2 disease with neoadjuvant treatments. 7 The de /uniFB01 nition of N2a or N2b disease will have a clinical contribution in order to determine the de /uniFB01 nition of operability in N2 disease and to provide clear evidence in which patient group surgery may be a treatment option. In this sense, the fact that the study population includes a special group is considered to be in line with the clinical presentation of staging.",
          "his staging will have a clear clinical contribution and how applicable it will be to clinicians."
        ]
      }
    ]
  },
  "statistics": [],
  "validation": {
    "checks": {
      "has_title": true,
      "has_authors": true,
      "authors_are_valid": false,
      "has_sections": true,
      "sections_have_content": true,
      "has_tables": false,
      "tables_have_captions": true,
      "tables_have_data": true,
      "has_figures": true,
      "figures_have_captions": false,
      "figures_have_images": false,
      "has_entities": false,
      "has_statistics": false,
      "has_references": true,
      "refs_structured": true,
      "refs_enriched_some": true,
      "references_enriched": true,
      "has_references_csv": false,
      "has_cross_refs": false,
      "umls_links": false,
      "figures_textual_count": 0
    },
    "completeness_score": 61,
    "is_valid": true,
    "issues": [],
    "warnings": [
      "No medical entities found",
      "No statistics extracted",
      "Some figures missing captions"
    ],
    "quality_level": "acceptable",
    "hardening": {
      "fixes": [
        {
          "field": "year",
          "action": "normalize:iso",
          "old": "2024-08",
          "new": 2024
        },
        {
          "field": "authors",
          "action": "filtered_ack_like",
          "old": [
            "Merve A. Türk"
          ],
          "new": [
            "Merve A. Türk"
          ]
        },
        {
          "field": "journal_full",
          "action": "canonicalize",
          "old": null,
          "new": "Journal of Thoracic Oncology"
        }
      ]
    }
  }
}